The Nitrosamine Implementation Oversight Group (NIOG) was set up by the European medicines regulatory network to oversee the harmonised implementation of the Article 5(3) CHMP opinion on nitrosamines in human medicinal products. The NIOG will be the main interface between regulators and industry to agree on topics requiring further scientific discussion. Click on the bottom to know more about the second meeting of the NIOG. The next meeting is expected to take place in September 2021.
June 30, 2021